Cargando…
Anti-SARS-CoV-2 antibody levels predict outcome in COVID-19 patients with type 2 diabetes: a prospective cohort study
Patients with type 2 diabetes (T2D) constitute one of the most vulnerable subgroups in COVID-19. Despite high vaccination rates, a correlate of protection to advise vaccination strategies for novel SARS-CoV-2 variants of concern and lower mortality in this high-risk group is still missing. It is fur...
Autores principales: | Mink, Sylvia, Saely, Christoph H., Leiherer, Andreas, Frick, Matthias, Plattner, Thomas, Drexel, Heinz, Fraunberger, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603091/ https://www.ncbi.nlm.nih.gov/pubmed/37884649 http://dx.doi.org/10.1038/s41598-023-45700-4 |
Ejemplares similares
-
Association between Lipid Levels, Anti-SARS-CoV-2 Spike Antibodies and COVID-19 Mortality: A Prospective Cohort Study
por: Mink, Sylvia, et al.
Publicado: (2023) -
Serotonin is elevated in risk-genotype carriers of TCF7L2 - rs7903146
por: Leiherer, Andreas, et al.
Publicado: (2019) -
Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis
por: Drexel, Heinz, et al.
Publicado: (2019) -
Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease
por: Leiherer, Andreas, et al.
Publicado: (2023) -
Serum uromodulin is associated with impaired glucose metabolism
por: Leiherer, Andreas, et al.
Publicado: (2017)